Click Here for 5% Off Your First Aladdin Purchase!

HLA Class II DRB1 Mouse mAb - Primary antibody, specific to HLA Class II DRB1, Mouse IgG2b

  • Azide Free
  • Carrier Free
  • ExactAb™
  • High performance
  • Validated
  • Lot by Lot
Features and benefits
  • Short Overview:

    mAb (C1); Mouse anti Human HLA Class II DRB1 Antibody; WB; Unconjugated

  • Species reactivity(Reacts with): Human
  • Isotype: Mouse IgG2b
    Application:
  • WB
Item Number
Ab108170
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab108170-10μl
10μl
In stock
$69.90
Ab108170-50μl
50μl
In stock
$199.90
Ab108170-100μl
100μl
In stock
$309.90
Ab108170-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,999.90

mAb (C1); Mouse anti Human HLA Class II DRB1 Antibody; WB; Unconjugated

Basic Description

Product NameHLA Class II DRB1 Mouse mAb - Primary antibody, specific to HLA Class II DRB1, Mouse IgG2b
SynonymsHLA-DRB1 | Human leukocyte antigen DRB1 | 2B1F_HUMAN antibody | DR1 antibody | DR16 antibody | DR5 antibody | DR8 antibody | DRB1 antibody | DRw10 antibody | DW2.2/DR2.2 antibody | FLJ75017 antibody | FLJ76359 antibody | HLA class II antigen beta chain an
Specifications & PurityExactAb™, Validated, Carrier Free, Azide Free, High performance, Lot by Lot
Host speciesMouse
SpecificityHLA Class II DRB1
ImmunogenRecombinant HLA-DRB1 expressed in E.coli (AA 30-266)
Positive ControlWB: Raji and Ramos cell lysates.
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, High performance, Validated
Product Description

Mouse anti Human HLA Class II DRB1 Antibody, Monoclonal (C1), could be used for WB and so on.
Application:
WB: 0.01-2 µg/mL

Product Properties

IsotypeMouse IgG2b
Light Chain Typekappa
SDS-PAGE150 kDa
Purification MethodProtein A purified + Protein G purified
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at 4℃ short term (1-2 weeks). Store at -20℃ long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle.

Images

HLA Class II DRB1 Mouse mAb (Ab108170) - Western Blot
All lanes: HLA Class II DRB1 Mouse mAb (Ab108170) at 1/2000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Mouse IgG H&L (HRP) (Ab179001) at 1/20000 dilution

Predicted band size: 30 kDa
Observed band size: 30 kDa
Exposure time: 12.1 s

HLA Class II DRB1 Mouse mAb (Ab108170) - Western Blot
All lanes: HLA Class II DRB1 Mouse mAb (Ab108170) at 1/2000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Mouse IgG H&L (HRP) (Ab179001) at 1/20000 dilution

Predicted band size: 30 kDa
Observed band size: 30 kDa
Exposure time: 49.9 s

Associated Targets

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-9 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-4 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-16 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-3 chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-12 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-13 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-8 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-11 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tchem HLA class II histocompatibility antigen, DRB1-15 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-1 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-14 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-7 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HLA-DRB1 Tbio HLA class II histocompatibility antigen, DRB1-10 beta chain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Application

ApplicationDilution info
WB

0.01-2 µg/mL

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0404380Certificate of AnalysisApr 10, 2024 Ab108170
ZJ24F0404379Certificate of AnalysisApr 10, 2024 Ab108170
ZJ24F0404378Certificate of AnalysisApr 10, 2024 Ab108170

Related Documents

References

1. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z et al..  (2011)  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis..  Nature,  476  (7359): (214-9).  [PMID:21833088]
2. Stephen W Scally,Jan Petersen,Soi Cheng Law,Nadine L Dudek,Hendrik J Nel,Khai Lee Loh,Lakshmi C Wijeyewickrema,Sidonia B G Eckle,Jurgen van Heemst,Robert N Pike,James McCluskey,Rene E Toes,Nicole L La Gruta,Anthony W Purcell,Hugh H Reid,Ranjeny Thomas,Jamie Rossjohn.  (2013-11-06)  A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis..  The Journal of experimental medicine,  210  ((12)): (2569-2582).  [PMID:24190431]
3. AeRyon Kim,Isamu Z Hartman,Brad Poore,Tatiana Boronina,Robert N Cole,Nianbin Song,M Teresa Ciudad,Rachel R Caspi,Dolores Jaraquemada,Scheherazade Sadegh-Nasseri.  (2014-11-22)  Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources..  Nature communications,  (5369-5369).  [PMID:25413013]
4. Tapeinou A, Giannopoulou E, Simal C, Hansen BE, Kalofonos H, Apostolopoulos V, Vlamis-Gardikas A, Tselios T..  (2018)  Design, synthesis and evaluation of an anthraquinone derivative conjugated to myelin basic protein immunodominant (MBP85-99) epitope: Towards selective immunosuppression..  Eur J Med Chem,  143  (621-631).  [PMID:29216561]
5. Jonsson, A K AK, Andersson, L L and Rask, L L..  (1989)  A cellular and functional split in the DRw8 haplotype is due to a single amino acid replacement (DR beta ser 57- asp 57)..  Immunogenetics,      [PMID:2497068]
6. Lee, B S BS, Rust, N A NA, McMichael, A J AJ and McDevitt, H O HO..  (1987)  HLA-DR2 subtypes form an additional supertypic family of DR beta alleles..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:2885840]
7. Tonnelle, C C, DeMars, R R and Long, E O EO..  (1985)  DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression..  The EMBO journal,      [PMID:2998758]
8. Young, J A JA, Wilkinson, D D, Bodmer, W F WF and Trowsdale, J J..  (1987)  Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genes..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:3110774]
9. Liu, C P CP, Bach, F H FH and Wu, S K SK..  (1988)  Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes..  Journal of immunology (Baltimore, Md. : 1950),    (15):   [PMID:3129499]
10. Lock, C B CB, So, A K AK, Welsh, K I KI, Parkes, J D JD and Trowsdale, J J..  (1988)  MHC class II sequences of an HLA-DR2 narcoleptic..  Immunogenetics,      [PMID:3259543]
11. Tieber, V L VL, Abruzzini, L F LF, Didier, D K DK, Schwartz, B D BD and Rotwein, P P..  (1986)  Complete characterization and sequence of an HLA class II DR beta chain cDNA from the DR5 haplotype..  The Journal of biological chemistry,    (25):   [PMID:3456344]
12. Wu, S K SK, Yabe, T T, Madden, M M, Saunders, T L TL and Bach, F H FH..  (1987)  cDNA cloning and sequencing reveals that the electrophoretically constant DR beta 2 molecules, as well as the variable DR beta 1 molecules, from HLA-DR2 subtypes have different amino acid sequences including a hypervariable region for a functionally important epitope..  Journal of immunology (Baltimore, Md. : 1950),    (1):   [PMID:3571980]
13. Cairns, J S JS and 5 more authors..  (1985)  Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants..  Nature,      [PMID:3875800]
14. Gustafsson, K K and 8 more authors..  (1984)  Mutations and selection in the generation of class II histocompatibility antigen polymorphism..  The EMBO journal,      [PMID:6589154]
15. Walker, L E LE and 5 more authors..  (1983)  N-terminal amino acid sequences of the alpha and beta chains of HLA-DR1 and HLA-DR2 antigens..  Biochemistry,    (4):   [PMID:6600932]
16. Kratzin, H H and 9 more authors..  (1981)  [Primary structure of class II human histocompatibility antigens. 1st communication. Amino acid sequence of the N-terminal 198 residues of the beta chain of a HLA-Dw2,2;DR2,2-alloantigen (author's transl)]..  Hoppe-Seyler's Zeitschrift fur physiologische Chemie,      [PMID:6947956]
17. Ghosh, P P, Amaya, M M, Mellins, E E and Wiley, D C DC..  (1995)  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3..  Nature,    (30):   [PMID:7477400]
18. Stern, L J LJ and 6 more authors..  (1994)  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide..  Nature,    (17):   [PMID:8145819]
19. Jardetzky, T S TS and 8 more authors..  (1994)  Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen..  Nature,    (21):   [PMID:8152483]
20. Topalian, S L SL and 7 more authors..  (1996)  Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes..  The Journal of experimental medicine,    (1):   [PMID:8642306]
21. Li, Q Q and 6 more authors..  (1997)  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes..  Journal of virology,      [PMID:9151859]
22. Dessen, A A, Lawrence, C M CM, Cupo, S S, Zaller, D M DM and Wiley, D C DC..  (1997)  X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II..  Immunity,      [PMID:9354468]
23. Martínez-Quiles, N N and 7 more authors..  (1998)  Complete cDNA sequence of the HLA-DRB1*09012 allele..  European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,      [PMID:9777332]
24. Smith, K J KJ, Pyrdol, J J, Gauthier, L L, Wiley, D C DC and Wucherpfennig, K W KW..  (1998)  Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein..  The Journal of experimental medicine,    (19):   [PMID:9782128]
25. Doebele, R C RC, Busch, R R, Scott, H M HM, Pashine, A A and Mellins, E D ED..  (2000)  Determination of the HLA-DM interaction site on HLA-DR molecules..  Immunity,      [PMID:11070170]
26. Petersson, K K and 6 more authors..  (2001)  Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence..  The EMBO journal,    (2):   [PMID:11432818]
27. Chen, X X, Ji, Z L ZL and Chen, Y Z YZ..  (2002)  TTD: Therapeutic Target Database..  Nucleic acids research,    (1):   [PMID:11752352]
28. Corell, A A and 5 more authors..  (2002)  Complete cDNA sequences of the HLA-DRB1*14011, *1402, *1403 and *1404 alleles..  Tissue antigens,      [PMID:11972886]
29. Ramon, D D and 5 more authors..  (2002)  Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles..  European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,      [PMID:12358860]
30. Kohsaka, Hitoshi H, Nasu, Kimio K, Matsushita, Sho S and Miyasaka, Nobuyuki N..  (2002)  Complete cDNA coding sequence of the HLA-DRB1*1405 allele..  DNA sequence : the journal of DNA sequencing and mapping,      [PMID:12652907]
31. Rossman, Milton D MD and 11 more authors..  (2003)  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites..  American journal of human genetics,      [PMID:14508706]
32. Arnon, Ruth R and Aharoni, Rina R..  (2004)  Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications..  Proceedings of the National Academy of Sciences of the United States of America,    (5):   [PMID:15371592]
33. Vilches, C C and 8 more authors..  (2005)  Complete coding sequences and haplotypic associations of HLA-B*0707, -B*1524, -B*4405, -B*4802, -DRB1*0409, -DRB1*0411, -DRB1*1115, -DRB1*1305, and the novel allele -DRB1*0709. Group-specific amplification of cDNA from DRB1 alleles associated to DRB3 and DRB4..  Tissue antigens,      [PMID:15896200]
34. Raymond, Christopher K CK and 10 more authors..  (2005)  Ancient haplotypes of the HLA Class II region..  Genome research,      [PMID:16140993]
35. Schulze zur Wiesch, Julian J and 16 more authors..  (2005)  Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes..  Journal of immunology (Baltimore, Md. : 1950),    (15):   [PMID:16148104]
36. Carlo-Stella, Carmelo C and 13 more authors..  (2006)  The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice..  Cancer research,    (1):   [PMID:16452241]
37. Balas, Antonio A and 7 more authors..  (2006)  Group-specific amplification of cDNA from DRB1 genes. Complete coding sequences of partially defined alleles and identification of the new alleles DRB1*040602, DRB1*111102, DRB1*080103, and DRB1*0113..  Human immunology,      [PMID:17174751]
38. Schmid, Dorothee D, Pypaert, Marc M and Münz, Christian C..  (2007)  Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes..  Immunity,      [PMID:17182262]
39. von Salomé, Jenny J, Gyllensten, Ulf U and Bergström, Tomas F TF..  (2007)  Full-length sequence analysis of the HLA-DRB1 locus suggests a recent origin of alleles..  Immunogenetics,      [PMID:17345114]
40. De Gassart, Aude A and 6 more authors..  (2008)  MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation..  Proceedings of the National Academy of Sciences of the United States of America,    (4):   [PMID:18305173]
41. Dephoure, Noah N and 6 more authors..  (2008)  A quantitative atlas of mitotic phosphorylation..  Proceedings of the National Academy of Sciences of the United States of America,    (5):   [PMID:18669648]
42. Fujiki, Fumihiro F and 15 more authors..  (2008)  A WT1 protein-derived, naturally processed 16-mer peptide, WT1(332), is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4(+) T cells..  Microbiology and immunology,      [PMID:19120973]
43. Harkiolaki, Maria M and 18 more authors..  (2009)  T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides..  Immunity,    (20):   [PMID:19303388]
44. Stumpf, Anita N AN and 5 more authors..  (2009)  Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity..  Blood,    (22):   [PMID:19706888]
45. Faner, Rosa R and 5 more authors..  (2010)  Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation..  European journal of immunology,      [PMID:19830726]
46. Zhu, F F and 8 more authors..  (2011)  Analysis of the complete cDNA sequences of HLA-DRB1 alleles with group-specific amplification primers in the Chinese Han population..  Tissue antigens,      [PMID:21388356]
47. Wang, Xin Xiang XX and 7 more authors..  (2011)  Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex..  Proceedings of the National Academy of Sciences of the United States of America,    (20):   [PMID:21900604]
48. Raychaudhuri, Soumya S and 14 more authors..  (2012)  Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis..  Nature genetics,    (29):   [PMID:22286218]
49. Kwok, William W and 8 more authors..  (2012)  Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire..  Journal of immunology (Baltimore, Md. : 1950),    (15):   [PMID:22327072]
50. Anguille, S S and 7 more authors..  (2013)  Identification of a Wilms' tumor 1-derived immunogenic CD4(+) T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes..  Leukemia,      [PMID:22929521]
51. Pos, Wouter W and 6 more authors..  (2012)  Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection..  Cell,    (21):   [PMID:23260142]
52. Goyette, Philippe P and 32 more authors..  (2015)  High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis..  Nature genetics,      [PMID:25559196]
53. Gerritsen, K E H KE, Groeneweg, M M, Meertens, C M H CM, Voorter, C E M CE and Tilanus, M G J MG..  (2015)  Full-length HLA-DRB1 coding sequences generated by a hemizygous RNA-SBT approach..  Tissue antigens,      [PMID:26396036]
54. Muehling, Lyndsey M LM and 5 more authors..  (2016)  Circulating Memory CD4+ T Cells Target Conserved Epitopes of Rhinovirus Capsid Proteins and Respond Rapidly to Experimental Infection in Humans..  Journal of immunology (Baltimore, Md. : 1950),    (15):   [PMID:27591323]
55. Wieczorek, Marek M and 6 more authors..  (2017)  Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation..  Frontiers in immunology,      [PMID:28367149]
56. Ooi, Joshua D and 24 more authors..  (2017)  Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells..  Nature,    (11):   [PMID:28467828]
57. Ting, Yi Tian YT and 10 more authors..  (2018)  The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis..  The Journal of biological chemistry,    (2):   [PMID:29317506]
58. Galperin, Moran M and 11 more authors..  (2018)  CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers..  Science immunology,    (8):   [PMID:29884618]
59. Yossef, Rami R and 10 more authors..  (2018)  Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy..  JCI insight,    (4):   [PMID:30282837]
60. Suzuki, Shingo S and 16 more authors..  (2018)  Reference Grade Characterization of Polymorphisms in Full-Length HLA Class I and II Genes With Short-Read Sequencing on the ION PGM System and Long-Reads Generated by Single Molecule, Real-Time Sequencing on the PacBio Platform..  Frontiers in immunology,      [PMID:30337930]
61. Meckiff, Benjamin J and 7 more authors..  (2019)  Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells..  Journal of immunology (Baltimore, Md. : 1950),    (1):   [PMID:31308093]
62. MacLachlan, Bruce J and 13 more authors..  (2019)  Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope..  The Journal of biological chemistry,    (27):   [PMID:31619516]
63. Greenshields-Watson, Alexander and 25 more authors..  (2020)  CD4+ T Cells Recognize Conserved Influenza A Epitopes through Shared Patterns of V-Gene Usage and Complementary Biochemical Features..  Cell reports,    (14):   [PMID:32668259]

Solution Calculators